• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by IQVIA Holdings Inc.

    6/2/25 5:22:00 PM ET
    $IQV
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $IQV alert in real time by email
    8-K
    false 0001478242 0001478242 2025-06-02 2025-06-02
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 2, 2025

     

     

    IQVIA HOLDINGS INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-35907   27-1341991

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    2400 Ellis Road

    Durham, North Carolina

      27703
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (919) 998-2000

    Not Applicable

    (Former name or former address, if changed since last report.)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class

     

    Trading

    Symbol

     

    Name of Each Exchange

    on which Registered

    Common Stock, par value $0.01 per share   “IQV”   New York Stock Exchange

     

     
     


    Item 8.01 Other Events

    On June 2, 2025, IQVIA Holdings Inc. (the “Company”) issued a press release announcing that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”) intends to raise $2,000,000,000 in gross proceeds through an offering of senior notes due 2032 (the “notes offering”) and intends to use the proceeds to repay existing borrowings under the Issuer’s revolving credit facility and to pay fees and expenses related to this offering, with any excess proceeds used for other general corporate purposes. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

    On June 2, 2025, the Issuer entered into a purchase agreement with the representative of the purchasers named therein, relating to the issuance and sale of $2,000,000,000 in aggregate principal amount of senior notes due 2032 bearing interest at a rate of 6.250% per annum. The consummation of the notes offering, which is expected to occur on or about June 4, 2025, is subject to the satisfaction of customary closing conditions. The Company also issued a press release announcing the pricing of the notes offering. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K.

    Item 9.01 Financial Statements and Exhibits

    (d) Exhibits.

     

    Exhibit No.    Description
    99.1    Launch press release dated June 2, 2025
    99.2    Pricing press release dated June 2, 2025
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: June 2, 2025

     

    IQVIA HOLDINGS INC.
    By:  

    /s/ Eric M. Sherbet

      Eric M. Sherbet
      Executive Vice President, General Counsel, and Secretary
    Get the next $IQV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IQV

    DatePrice TargetRatingAnalyst
    4/25/2025$160.00Buy → Hold
    HSBC Securities
    4/10/2025$170.00Overweight → Equal Weight
    Barclays
    2/3/2025Buy → Neutral
    BTIG Research
    12/20/2024$250.00Overweight
    Stephens
    10/14/2024Buy
    Redburn Atlantic
    9/4/2024$275.00Outperform
    RBC Capital Mkts
    7/24/2024$266.00 → $242.00Buy → Hold
    Jefferies
    6/6/2024$270.00Buy
    Goldman
    More analyst ratings